As one of the fastest growing markets and fields in the 21st century, nanotechnology is driving remarkable innovations across a variety of disciplines. Most recently, nanotechnology has become even further engrained in advancements within the
medical field.
Doctors have used nanotechnology in cancer treatments for more than a decade, and according to AzoNano, at present, researchers are developing novel therapeutics with newly discovered nanoparticles that have novel properties to be leveraged in medical science. Also, nanotechnology enhances chemotherapy while also reducing the effects by guiding the chemotherapy drugs to selectively target cancer cells.
This same technology became widespread news over the past year as it was applied to vaccine research, most notably the COVID-19 vaccine, as lipid nanoparticles are a vital component of the new
Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, playing a key role in protecting and transporting the mRNA effectively to the right place in cells. (Source:
CAS)
According to the "
Global Nanotechnology in Medical Devices Market Segmentation, Parameters, Prospects 2021 And Forecast Research Report To 2027", the Nanotechnology in medical devices market is expected to reach a market value of USD 20.52 billion by 2027 growing with the CAGR of 11.9% in the forecast period of 2020-2027. This is attributed to increasing support of the government in the provision on advanced technology.
Nanotechnology has also been a huge factor in the development of wearable technologies for health and wellness monitoring and recreation. As more people are wearing smart watches or any other type of mobile device, there is a now a new need for constant charging capabilities.
Silicon Republic reports that by 2027, technology that converts human motion into electricity using “triboelectric nanogenerator (TENG) technology” could be available. This would enable a way to capture power from human motion. Should this be successful, materials with this technology could be incorporated into clothing and used to charge
mobile devices.
The advancements being made in the field of nanotechnology are essential for the sustainability and improvement of societal well-being. And therefore, accessibility to the latest research discoveries through openly available content is key. We are pleased to take this opportunity to introduce the
International Journal of Applied Nanotechnology Research (IJANR), a premier gold open access journal published by IGI Global. It focuses on prevalent trending topics such as those mentioned above along with a plethora of others and is aimed at promoting emerging research in nanotechnology, human health, environmental well-being, green and sustainable manufacturing, and better diagnosis and treatments in medicine.
IJANR’s scope covers many topics, including:
- Nanomedical Devices
- Nanomedicine
- Nanobiotechnology
- Engineering Applications and Environmental Engineering of Materials
- Green and Sustainable Manufacturing and Remediation
- Biorenewable Materials
- Pharmacokinetics of Nanomaterials
- Toxicology of Nanomaterials
- And Many More
The journal is currently accepting new submissions for consideration. If interested in submitting an article manuscript to IJANR for consideration, you can begin the submission process through our eEditorial Discovery® system. As a gold open access journal, an Article Processing Charge (APC) is required, however, will not be requested until AFTER the article manuscript has undergone the full double-blind peer review process and is accepted into the journal (Note: If an article manuscript is rejected, there will be no APC fee requested). The APC fee, US $750, paid directly to IGI Global by either the author or a funding body, offsets the costs associated with publishing an article under OA. IGI Global does have various options available for those who may encounter difficulties securing OA funding. Learn more through our Open Access page.
To explore recently published articles in IJANR, visit the Table of Contents page. For any further inquiries or questions about IJANR, please contact the journal’s editor-in-chief, Prof. Bakhtiyor Rasulev, at rasulev@icnanotox.org. If you are interested in learning more about open access publishing with IGI Global, please contact us at: openaccessadmin@igi-global.com.
About IGI Global
Founded in 1988, IGI Global, an international academic publisher, is committed to producing the highest quality research (as an active full member of the Committee on Publication Ethics “COPE”) and ensuring the timely dissemination of innovative research findings through an expeditious and technologically advanced publishing process. Through their commitment to supporting the research community ahead of profitability, and taking a chance on virtually untapped topic coverage, IGI Global has been able to collaborate with over 150,000+ researchers from some of the most prominent research institutions around the world to publish the most emerging, peer-reviewed research across 350+ topics in 11 subject areas including business, computer science, education, engineering, social sciences, and more.
Learn More About IGI Global >
Newsroom Contact
Author Relations Team
(717) 533-8845
authorrelations@igi-global.com
www.igi-global.com